Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3427584
Max Phase: Preclinical
Molecular Formula: C73H106F2N21O24PS
Molecular Weight: 1762.81
Molecule Type: Small molecule
Associated Items:
ID: ALA3427584
Max Phase: Preclinical
Molecular Formula: C73H106F2N21O24PS
Molecular Weight: 1762.81
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC(=O)CC[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](CCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)NC(=O)CCCCCn2cc(nn2)C[C@H](C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccc(C(F)(F)P(=O)(O)O)cc2)NC1=O
Standard InChI: InChI=1S/C73H106F2N21O24PS/c74-73(75,121(118,119)120)39-18-16-38(17-19-39)32-47-66(111)86-44(21-25-54(77)98)70(115)95-30-8-11-50(95)68(113)81-35-58(102)83-42(22-26-59(103)104)64(109)89-48(34-55(78)99)67(112)87-46(62(79)107)33-40-36-94(93-92-40)29-7-1-2-15-57(101)82-41(10-5-6-28-80-56(100)14-4-3-13-52-61-49(37-122-52)90-72(117)91-61)63(108)85-45(23-27-60(105)106)71(116)96-31-9-12-51(96)69(114)84-43(65(110)88-47)20-24-53(76)97/h16-19,36,41-52,61H,1-15,20-35,37H2,(H2,76,97)(H2,77,98)(H2,78,99)(H2,79,107)(H,80,100)(H,81,113)(H,82,101)(H,83,102)(H,84,114)(H,85,108)(H,86,111)(H,87,112)(H,88,110)(H,89,109)(H,103,104)(H,105,106)(H2,90,91,117)(H2,118,119,120)/t41-,42+,43+,44+,45+,46-,47+,48+,49+,50+,51+,52+,61+/m1/s1
Standard InChI Key: ALHHKGJWXVOEHN-CXVNKNBPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1762.81 | Molecular Weight (Monoisotopic): 1761.7146 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Meyer C, Hoeger B, Chatterjee J, Köhn M.. (2015) Azide-alkyne cycloaddition-mediated cyclization of phosphonopeptides and their evaluation as PTP1B binders and enrichment tools., 23 (12): [PMID:25805211] [10.1016/j.bmc.2015.03.015] |
Source(1):